TrialThe pharmacogenomics journal2015

Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.

K L Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.